$19.71
1.65%
Nasdaq, Sep 25, 04:00 pm EDT. Closed.

Privia Health Group Target price 2026 - Analyst rating & recommendation

Privia Health Group Classifications & Recommendation

Buy
92%
Hold
8%

Privia Health Group Price Target

Target Price $31.62
Price $19.71
Potential
Number of Estimates 20
20 Analysts have issued a price target Privia Health Group 2027 . The average Privia Health Group target price is $31.62. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 25 analysts: 23 Analysts recommend Privia Health Group to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Privia Health Group stock has an average upside potential 2027 of . Most analysts recommend the Privia Health Group stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 2.12 2.50
22.26% 17.96%
EBITDA Margin 2.08% 6.21%
48.88% 198.66%
Net Margin 1.08% 1.35%
30.28% 25.04%

20 Analysts have issued a sales forecast Privia Health Group 2026 . The average Privia Health Group sales estimate is

$2.5b
unlock
. This is
6.19% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.6b 11.49%
unlock
, the lowest is
$2.4b 0.46%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $2.1b 22.26%
2026
$2.5b 17.96%
unlock
2027
$2.7b 9.66%
unlock
2028
$3.1b 11.33%
unlock
2029
$3.2b 4.55%
unlock
2030
$3.5b 9.76%
unlock
2031
$3.5b 1.05%
unlock

20 Analysts have issued an Privia Health Group EBITDA forecast 2026. The average Privia Health Group EBITDA estimate is

$155m
unlock
. This is
172.94% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$164m 187.16%
unlock
, the lowest is
$147m 158.34%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $44.1m 82.02%
2026
$155m 252.08%
unlock
2027
$177m 14.00%
unlock
2028
$205m 15.73%
unlock
2029
$223m 8.95%
unlock
2030
$251m 12.17%
unlock
2031
$299m 19.44%
unlock

EBITDA Margin

2025 2.08% 48.88%
2026
6.21% 198.66%
unlock
2027
6.45% 3.86%
unlock
2028
6.71% 4.03%
unlock
2029
6.99% 4.17%
unlock
2030
7.14% 2.15%
unlock
2031
8.62% 20.73%
unlock

21 Privia Health Group Analysts have issued a net profit forecast 2026. The average Privia Health Group net profit estimate is

$33.7m
unlock
. This is
19.95% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$42.4m 50.89%
unlock
, the lowest is
$22.3m 20.77%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $22.9m 59.28%
2026
$33.7m 47.16%
unlock
2027
$54.8m 62.50%
unlock
2028
$73.6m 34.30%
unlock

Net Margin

2025 1.08% 30.28%
2026
1.35% 25.04%
unlock
2027
2.00% 48.15%
unlock
2028
2.41% 20.50%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 0.18 0.27
63.64% 50.00%
P/E 73.80
EV/Sales 0.84

21 Analysts have issued a Privia Health Group forecast for earnings per share. The average Privia Health Group EPS is

$0.27
unlock
. This is
22.73% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$0.34 54.55%
unlock
, the lowest is
$0.18 18.18%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $0.18 63.64%
2026
$0.27 50.00%
unlock
2027
$0.43 59.26%
unlock
2028
$0.58 34.88%
unlock

P/E ratio

Current 89.59 51.94%
2026
73.80 17.63%
unlock
2027
45.42 38.46%
unlock
2028
33.82 25.54%
unlock

Based on analysts' sales estimates for 2026, the Privia Health Group stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.89 28.23%
2026
0.84 5.53%
unlock
2027
0.77 8.81%
unlock
2028
0.69 10.17%
unlock
2029
0.66 4.34%
unlock
2030
0.60 8.89%
unlock
2031
0.61 1.07%
unlock

P/S ratio

Current 1.07 26.11%
2026
1.01 5.83%
unlock
2027
0.92 8.81%
unlock
2028
0.82 10.17%
unlock
2029
0.79 4.36%
unlock
2030
0.72 8.89%
unlock
2031
0.73 1.06%
unlock

Current Privia Health Group Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Barclays
Locked
➜
Locked
Locked May 26 2026
Canaccord Genuity
Locked
➜
Locked
Locked May 08 2026
Evercore ISI Group
Locked
➜
Locked
Locked Apr 08 2026
Barclays
Locked
➜
Locked
Locked Mar 25 2026
Citigroup
Locked
➜
Locked
Locked Mar 03 2026
Truist Securities
Locked
➜
Locked
Locked Mar 02 2026
Canaccord Genuity
Locked
➜
Locked
Locked Feb 27 2026
Analyst Rating Date
Locked
Barclays:
Locked
➜
Locked
May 26 2026
Locked
Canaccord Genuity:
Locked
➜
Locked
May 08 2026
Locked
Evercore ISI Group:
Locked
➜
Locked
Apr 08 2026
Locked
Barclays:
Locked
➜
Locked
Mar 25 2026
Locked
Citigroup:
Locked
➜
Locked
Mar 03 2026
Locked
Truist Securities:
Locked
➜
Locked
Mar 02 2026
Locked
Canaccord Genuity:
Locked
➜
Locked
Feb 27 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today